Deportations Sending Addiction over the Border? Treating Drug Use in Tijuana | Patricia Zuniga, MD
This presentation is part of the 2020 State of the Art in Addiction Medicine conference which covers an expansion of treatment into correctional health, hospital consultation services and emergency rooms. It will cover how, despite the pandemic, telehealth can reach those who are isolated. It will address the worrisome trends in fentanyl, methamphetamine, tobacco and benzodiazepines use; legalization of cannabis, treatment updates for youth, cannabis and alcohol in pregnant women; and novel treatments such as non-benzodiazepines for alcohol withdrawal and psychedelics for substance use disorders.
Learners cannot sign up for individual lectures, only for the full 2020 State of the Art in Addiction Medicine. Please contact CSAM (email@example.com) if you have any questions about this online educational offering.
Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
- Primary care, psychiatry and other specialty field clinicians who want a better understanding of addiction and to improve their care of patients with unhealthy substance use
- Public policy makers, administrators and advocates who want an understanding of the current state of the field of addiction and its grater implications including towards prevention, access to care, integrated systems of care and healthcare technology
- Other healthcare professionals, including psychologists, therapists, nurses, and addiction counselors, who are involved in the treatment of patients with or at risk of substance use
- Understand the intersections of US immigration policy, policing, substance use, and health in Mexican border cities, such as Tijuana.
- Understand the common challenges and burdens that marginalized communities, including deportees and injection drug users, experience in accessing care in Mexican border cities, such as Tijuana.
- Understand the unique role that harm reduction organizations, such as the Wound Clinic, play in increasing awareness about the urgent need for humane and respectful interventions that include mental health and substance use treatment for marginalized communities in Mexican border cities, such as Tijuana.
Patricia E. Zuniga, MD
Patricia Gonzalez-Zuñiga, MD | HIV/AIDS specialist, Global Health Institute at University of California, San Diego and Founder, Tijuana Wound Clinic. Dr. Gonzalez-Zuñiga is a clinician with more than 20 years of experience working with underserved and marginalized populations in the US-Mexico border region in the field of HIV care along with interest in HIV prevention from a public health perspective. She is the founder and director of Wound Clinic/Clínica de Heridas, an independent mobile clinic based in Tijuana, and Casa del Centro, Creative Transformation Center focused on providing humanitarian medical assistance to underserved people irrespective of their socioeconomic status, political and religious affiliations, gender, race, migration status, or substance dependency background based on their needs. Dr. Gonzalez-Zuñiga has served as a clinician, researcher, and coordinator of the El CUETE Phase IV research project from 2012 to 2020 which evaluates the impact of drug policy reform on the HIV risk environment among people who inject drugs.
DISCLOSURE: No relevant financial relationships to disclose
The California Society of Addiction Medicine (CSAM) is accredited by the California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credits™, Physicians should only claim credit commensurate with the extent of their participation in the activity.
Continuing education credit is available for psychologists, therapists, substance use counselors, nurses and physician assistants.
(see additional information on page for parent course)
- 1.00 AMA Category 1
- 1.00 Attendance